Advion BioSystems and Agilent Technologies Announce Co-Marketing Agreement
News Nov 18, 2008
Advion BioSystems, Inc. and Agilent Technologies Inc. have jointly announced that they have signed a non-exclusive co-marketing agreement to co-promote the Advion TriVersa NanoMate system with Agilent mass spectrometers.
The TriVersa NanoMate is an automated fraction collection and nanoelectrospray system that connects to the inlet of a mass spectrometer. It combines the benefits of micro or capillary-scale liquid chromatography (LC), with simultaneous fraction collection and subsequent chip-based infusion of the LC fractions in one system to increase the performance and automation of a mass spectrometer.
The TriVersa NanoMate differs from Agilent’s 1200 Series HPLC-Chips in that the former operates at capillary and micro flow rates needed for fraction collection, enabling collection of individual peaks for highly sensitive infusion MS analysis. The latter provides on-line LC/MS at nanoflow rates that are well-suited to applications where the amount of sample available is limited.
Agilent and Advion have co-developed a bracket to interface the TriVersa NanoMate to Agilent mass spectrometers to provide life science users with the power of automated sample infusion on the Agilent family of LC/MS systems.
Under the agreement, the companies will co-market the TriVersa NanoMate and Agilent mass spectrometer systems with each company responsible for its individual products.
Agilent will sell and support its mass spectrometers and Advion will sell and support the TriVersa NanoMate and the bracket to interface the TriVersa NanoMate to Agilent mass spectrometers. Each company will co-promote their products at industry tradeshows and conferences.
“The combination of the TriVersa NanoMate with Agilent mass spectrometers provides a powerful tool for life science researchers,” said Jack Henion, Advion’s Chief Scientific Officer. “In particular, the efficiency and sensitivity of direct infusion of LC fractions with the TriVersa NanoMate and the new Agilent 6530 Accurate-Mass Q-TOF instrument provides researchers with exceptional sensitivity and speed for proteomics, metabolism, lipidomics, and biomarker applications.”